Category: K417N
Efficacy of the AstraZeneca coronavirus vaccine against the B.1.351 South African Variant
Study conclusions: A two-dose regimen of the ChAdOx1 nCoV-19 [AstraZeneca] vaccine did not show protection against mild-to-moderate Covid-19 due to the B.1.351 [South Africa ] variant. More...
South African coronavirus variant B.1.351 (501Y.V2) at around 15% in Saarland, Germany
German Federal Health Jens Spahn Minister of has expressed concern about the spread of the South African corona variant in Saarland . More...
Lancet: Surveillance of coronavirus in Zimbabwe shows dominance of variants of concern – B.1.351 (501Y.V2) and A.23.1
In December, 2020, 95 (89%) of 107 sequenced cases contained mutations of concern, rising to 102 (98%) of 104 in January, 2021. More...
Antibody resistance of coronavirus variants B.1.351 (SA) and B.1.1.7 (UK)
“Findings on B.1.351 [South Africa variant] are more worrisome in that this variant is not only refractory to neutralization by most NTD mAbs but also by multiple individual mAbs to the receptor-binding motif on RBD, largely owing to an E484K mutation. More...
More than 450 cases of the South African coronavirus variant 501Y.V2 diagnosed in Israel
Over 450 cases of the South Africa coronavirus variant 501Y.V2 More...
Three cases of South African coronavirus variant B.1.351 confirmed in Czech kindergarten
Elisabeth Pharmacon laboratory in Brno, Czech Republic has detected three cases of the South African mutation of the coronavirus, in samples taken in a local kindergarten. More...
Pfizer says South African variant 501Y.V2 B.1.351 could reduce vaccine protection by up to 66%
A laboratory study suggests that the South African variant of the coronavirus N501Y.V2 More...
Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 and B.1.351/501Y-V2
“As of 7th Jan 2021, 45 countries had reported the presence of B.1.1.7 and 13 countries had reported B.1.351/501Y.V2. More...